Two 59%+ winners, four above 25% in Aug – How this AI model keeps picking winners
Citi has affirmed its Buy rating on shares of Huntington Bancshares (NASDAQ: NASDAQ:HBAN), maintaining a price target of $18.00 as the firm revised its earnings per share (EPS) estimates following the second-quarter 10-Q disclosures and adjustments to the projected interest rates curve.
For the year 2024, the estimated EPS is now set at $1.15, down 5 cents from the previous forecast, which is slightly below the FactSet consensus of $1.19. The EPS forecast for 2025 has been reduced by 10 cents to $1.35, compared to the FactSet consensus of $1.38. The 2026 EPS estimate remains unchanged at $1.65, which is above the FactSet consensus of $1.56.
The bank's financial performance and projections are closely monitored by investors, as changes in earnings expectations can influence stock performance. Citi's analysis reflects a careful consideration of Huntington Bancshares' recent financial disclosures and the anticipated trajectory of interest rates, which are critical factors for the banking sector.
Huntington Bancshares reported second-quarter earnings of $0.30 per share, exceeding consensus estimates. This led to various firms adjusting their outlooks, including Baird, which downgraded the bank's stock to Neutral from Outperform, with a new price target of $15.00, reflecting a cautious stance after a significant uptick in the bank's share performance.
On the other hand, DA Davidson raised its price target to $17.50, citing the company's consistent 2024 outlook. Similarly, Argus raised the stock price target for Huntington Bancshares to $16.00, highlighting the bank's healthy growth in deposits. Stephens also increased its price target to $16, acknowledging the company's deposit growth and income trends as significant factors.
Piper Sandler initially raised its price target to $13.50 but later downgraded the company to Neutral, reducing its price target to $11.50. Other firms such as RBC Capital and JPMorgan maintained a positive outlook, with RBC Capital maintaining an Outperform rating and raising its price target to $17, while JPMorgan upgraded the company from Neutral to Overweight and raised its price target to $18.00.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.